Melphalan
Melphalan (often recognised by the brand name Alkeran) is a targeted cytotoxic agent used to manage certain malignant conditions by inhibiting cell growth. Our database currently lists 1 product, Alkacel, reflecting the focused nature of this treatment. Patients can browse available information on this page to better understand their clinical therapy.
Key points
- An alkylating cytotoxic agent used mainly for multiple myeloma, with a secondary role in ovarian cancer treatment.
- Works by disrupting DNA replication in abnormal cells, which is why its use is restricted to specialist oncology settings.
- Can suppress bone marrow function alongside nausea or mucosal irritation, so blood counts are checked regularly during treatment.
What is Melphalan?
Melphalan acts as an alkylating agent. It works by interfering with the DNA replication process within cells, which limits the ability of certain abnormal cells to multiply. Due to its mechanism, this medication is strictly used within specialised clinical settings under direct oncological oversight.
What Melphalan is used for
This medication is primarily indicated for the management of Multiple Myeloma. It may also be applied as part of a therapeutic regimen for Ovarian Cancer. Its role is to inhibit the progression of these malignancies, supporting long-term disease control and patient management.
Melphalan brands and forms
Generics provide alternative options for therapy, with the originator brand Alkeran historically setting the therapeutic standard. As part of Oncology Support, clinicians select specific preparations based on the needs of the treatment plan. This listing includes the film-coated tablet form, which offers a structured method for regular dosing.
Safety overview for Melphalan
What to check before using this medicine
A thorough medical evaluation is required to assess suitability. Factors such as baseline blood counts and organ health must be reviewed by an oncologist.
Possible reactions and tolerability
As a cytotoxic agent, this medication may influence healthy cells, potentially leading to myelosuppression, nausea, or mucosal irritation. Regular blood monitoring is standard practice to manage tolerability.
Interactions and health factors
Other treatments, supplements, and pre-existing conditions can interfere with how this medicine works. Provide a complete list of all current medications to your medical team. Product labelling and verified clinical sources remain the correct references for specific contraindications, interactions and reactions.